Mirae Asset Global Investments
FHTX icon

Mirae Asset Global Investments’s Foghorn Therapeutics FHTX Stock Holding History

Mirae Asset Global Investments’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Sell
2,626
-430
-14% -$1.91K ﹤0.01% 1544
2026
Q1 		$14.6K Buy
3,056
+308
+11% +$1.69K ﹤0.01% 1463
2025
Q4 		$14.8K Buy
2,748
+563
+26% +$2.55K ﹤0.01% 1574
2025
Q3 		$10.7K Buy
2,185
+32
+1% +$170 ﹤0.01% 1569
2025
Q2 		$10.1K Buy
2,153
+292
+16% +$1.22K ﹤0.01% 1491
2025
Q1 		$6.55K Buy
1,861
+8
+0.4% +$36 ﹤0.01% 1503
2024
Q4 		$8.93K Buy
+1,853
New +$13.5K ﹤0.01% 1525

Other funds holding FHTX

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BFS
Bare Financial Services Gap, Pennsylvania $436M AUM 20.22% 1-Year Est. Return

Mirae Asset Global Investments's FHTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Foghorn Therapeutics (FHTX) stake by 14% in Q2 2026, selling an estimated $1.91K and leaving 2,626 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Mirae Asset Global Investments first reported a position in FHTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.8K in Q4 2025. 19 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Mirae Asset Global Investments held 2,626 shares of Foghorn Therapeutics worth $12.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 430 Foghorn Therapeutics shares in Q2 2026, an estimated $1.91K.
  • Foghorn Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1544 holding.
  • Mirae Asset Global Investments first reported a position in Foghorn Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Foghorn Therapeutics position peaked at $14.8K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.